Dashboard MRSA
Repurposing candidates for MRSA
Methicillin-resistant Staphylococcus aureus
Approved medicines with AI-predicted activity ≥40% against MRSA, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 860
- Existing antimicrobials set aside
- 117
- Needing review
- 72
- Repurposing candidates
- 671
Repurposing candidates for MRSA
AI prediction · nothing measuredAll 671 repurposing candidates for MRSA.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- PrednicarbateExisting use: Allergic conjunctivitis, Allergic rhinitis, Ankylosing spondylitis and 56 more51.7% AI-predicted activityagainst MRSA3 registered studies
- TelaprevirExisting use: Chronic hepatitis C virus infection, Viral disease51.7% AI-predicted activityagainst MRSA50+ registered studies
- Ergotamine TartrateExisting use: Headache, Migraine disorder51.7% AI-predicted activityagainst MRSA10 registered studies
- LubiprostoneExisting use: Chronic pain, Constipation, Constipation disorder and 1 more51.7% AI-predicted activityagainst MRSA50+ registered studies
- Testosterone EnanthateExisting use: Cancer, Hypogonadism, Hypogonadotropic hypogonadism and 5 more51.7% AI-predicted activityagainst MRSA50+ registered studies
- Testosterone UndecanoateExisting use: Cancer, Hypogonadism, Hypogonadotropic hypogonadism and 5 more51.7% AI-predicted activityagainst MRSA50+ registered studies
- Tenapanor HydrochlorideExisting use: Constipation, Constipation disorder, Irritable bowel syndrome51.6% AI-predicted activityagainst MRSA2 registered studies
- LusutrombopagExisting use: Hemorrhage, Thrombocytopenia51.6% AI-predicted activityagainst MRSA8 registered studies
- ChlorthalidoneExisting use: Angina pectoris, Cardiovascular disease, Chronic kidney disease and 6 more51.5% AI-predicted activityagainst MRSA50+ registered studies
- Etoposide PhosphateExisting use: Cancer, Lung cancer, Lung neoplasm and 3 more51.5% AI-predicted activityagainst MRSA50+ registered studies
- CholecalciferolExisting use: Anemia (phenotype), Iron deficiency anemia, Osteoporosis51.5% AI-predicted activityagainst MRSA50+ registered studies
- LifitegrastExisting use: Dry eye syndrome, Eye disease51.5% AI-predicted activityagainst MRSA39 registered studies
- Copanlisib DihydrochlorideExisting use: Follicular lymphoma, Neoplasm, Neoplasm of mature B-cells51.4% AI-predicted activityagainst MRSA10 registered studies
- TrifaroteneExisting use: Acne51.4% AI-predicted activityagainst MRSA14 registered studies
- ChlordiazepoxideExisting use: Alcohol dependence, Anxiety, Anxiety disorder51.4% AI-predicted activityagainst MRSA8 registered studies
- LotilanerExisting use: Eye infection51.4% AI-predicted activityagainst MRSA14 registered studies
- SaquinavirExisting use: HIV infection, HIV-1 infection, Viral disease51.4% AI-predicted activityagainst MRSA50+ registered studies
- FluorometholoneExisting use: Acne, Eye inflammation, Hemorrhoid and 1 more51.3% AI-predicted activityagainst MRSA37 registered studies
- EntecavirExisting use: Chronic hepatitis B virus infection, Hepatitis B virus infection, Liver disease and 1 more51.3% AI-predicted activityagainst MRSA50+ registered studies
- Fluticasone PropionateExisting use: Airway obstruction, Allergic rhinitis, Asthma and 9 more51.3% AI-predicted activityagainst MRSA50+ registered studies
- Flortaucipir F-18Existing use: Alzheimer disease, Cognitive impairment, Neurodegenerative disease51.3% AI-predicted activityagainst MRSA30 registered studies
- PonesimodExisting use: Multiple sclerosis, Relapsing-remitting multiple sclerosis51.3% AI-predicted activityagainst MRSA22 registered studies
- EluxadolineExisting use: Diarrheal disease, Irritable bowel syndrome51.2% AI-predicted activityagainst MRSA10 registered studies
- Niraparib TosylateExisting use: Cancer, Fallopian Tube Carcinoma, Neoplasm and 3 more51.1% AI-predicted activityagainst MRSA7 registered studies